Dry Needling for Shoulder Pain in Stroke Patients

Stroke Clinical Trial

Official title:

Dry Needling for Shoulder Pain and Presence of Post-needling Induced-Pain in PAtients Who Had Suffered a Stroke

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03703193
• Other study ID #: URJC1512201600817
• Status: Completed
• Phase: N/A
• Start date: October 19, 2018
• Est. completion date: December 21, 2018

Study information

• Verified date: December 2018
• Source: Universidad Rey Juan Carlos
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Spasticity and pain, particularly int he shoulder region, are the most common impairments experienced by subjects who had experienced a stroke. There is preliminary evidence supporting the role of dry needling for spasticity in patients who had suffered from a stroke. Few data exists on the effects on shoulder pain. In addition, it has been shown that application of dry needling induces post-needling soreness in individuals with musculoskeletal pain. No previous study has investigated the presence and the duration of post-needling soreness in individuals who had experienced a stroke.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 16
• Est. completion date: December 21, 2018
• Est. primary completion date: December 21, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 30 Years to 60 Years

Eligibility

Inclusion Criteria:

• first-ever unilateral stroke;

• hemiplegia resulting from stroke;

• age between 30 and 60 years old;

• presence of hypertonicity in the upper extremity;

• pain symptoms in the shoulder

• active trigger points in the shoulder muscles reproducing the shoulder pain symptoms

Exclusion Criteria:

• recurrent stroke;

• absence of active trigger points in the shoulder muscles reproducing shoulder symptoms

• previous treatment with nerve blocks, motor point injections with neurolytic agents for spasticity at any time;

• previous treatment with botulinum toxin-A in the 6 months prior the study;

• severe cognitive deficits;

• other neurologic diseases,

• underlying complex medical conditions, e.g., heart conditions, unstable hypertension, fracture

• fear to needles;

• any contraindication for deep dry needling, e.g., anticoagulants, infections, bleeding, or psychotic.

Related Conditions & MeSH terms

• Shoulder Pain
• Stroke

Intervention

Other:
• Dry Needling
A single session of modulatory interventions combined with a single session of dry needling into the shoulder muscles which active trigger points will reproduce the shoulder pain symptoms.
• Physical Therapy
A single session of modulatory interventions targeting modulation of central nervous system.

Locations

Country	Name	City	State
Spain	César Fernández-de-las-Peñas	Alcorcon	Madrid

Sponsors (1)

Lead Sponsor	Collaborator
Universidad Rey Juan Carlos

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in post-dry needling pain intensity with a numerical pain rate scale before and after the intervention	A Numerical Pain Rate Scale (NPRS, 0-10) will be used to record post-dry needling soreness in the targeted area	Baseline, 24 hours (1 day) after and 72 hours (3 days) after treatment the intervention
Secondary	Changes in spontaneous shoulder pain with a numerical pain rate scale before and after the intervention	A Numerical Pain Rate Scale (NPRS, 0-10) will be used to assess spontaneous shoulder pain	Baseline, 72 hours (3 days) and 168 hours (7 days) after treatment the intervention
Secondary	Presence of active trigger points in the shoulder musculature	Manual palpation of active trigger points in the shoulder muscles will be conducted	Baseline, 72 hours (3 days) and 168 hours (7 days) after treatment the intervention